The upgrade of Edwards Lifesciences by B of A Securities from Neutral to Buy is a strong positive signal to the market, indicating a bullish outlook on the company's future performance. Such upgrades typically lead to increased investor confidence and can drive up the stock price in the short term as market participants adjust their positions based on the new information.